Skip to content

Search

NDIA backs The Kids Research Institute Australia's program to support babies developing differently

A world-first program for babies with delays in their social and communication skills has been launched in Western Australia, thanks to support from the National Disability Insurance Agency (NDIA).

Renowned Autism Researcher named Western Australian of the Year

Autism researcher Professor Andrew Whitehouse has been named this year’s Western Australian of the Year in the HBF Professions category.

Therapy for babies with signs of autism cuts long-term disability costs

New research evaluating the potential cost savings of a therapy for babies displaying early autism signs has predicted a three dollar return to Australia’s National Disability Insurance Scheme (NDIS) for every dollar invested in therapy.

Autism researcher a finalist for WA's Australian of the Year

Professor Andrew Whitehouse, who has helped transform clinical support for children on the autism spectrum in Australia, is nominated for WA's 2023 Australian of the Year.

Autism researcher the youngest-ever Fellow of prestigious academy

Professor Andrew Whitehouse has been inducted as the youngest-ever Fellow to the Australian Academy of Health and Medical Sciences.

WA duo recognised as world’s most frequent autism research collaborators of the decade

Director of CliniKids, Professor Andrew Whitehouse, and Professor Murray Maybery, have been identified as the world’s most frequent autism research collaborators of the decade.

CliniKids clinicians rise to the COVID-19 challenge

The CliniKids team has reimagined how allied health services for children with autism spectrum disorder or developmental delays are delivered.

World-first video trial to help babies at risk of autism thrive

Video technology is helping researchers learn more about the early communication style of infants with a family history of autism, ADHD or intellectual disability.

Feasibility of a 2-minute eye-tracking protocol to support the early identification of autism

We tested the potential for Gazefinder eye-tracking to support early autism identification, including feasible use with infants, and preliminary concurrent validity of trial-level gaze data against clinical assessment scores. We embedded the ~ 2-min 'Scene 1S4' protocol within a comprehensive clinical assessment for 54 consecutively-referred, clinically-indicated infants (prematurity-corrected age 9-14 months).

Support Preferences and Clinical Decision Support Systems (CDSS) in the Clinical Care of Autistic Children: Stakeholder Perspectives

Clinical decision support systems (CDSS) are increasingly utilised within healthcare settings to enhance decision making. However, few studies have investigated their application in the context of clinical services for autistic people, with no research to date exploring the perspectives of the key stakeholders who are, or in the future may be, impacted by their use.